WealthPLAN Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.36M | Sell |
9,387
-7,628
| -45% | -$1.64M | 0.45% | 55 |
|
|
2026
Q1 | $3.7M | Sell |
17,015
-3,402
| -17% | -$755K | 0.72% | 36 |
|
|
2025
Q4 | $4.67M | Sell |
20,417
-2,067
| -9% | -$471K | 0.7% | 38 |
|
|
2025
Q3 | $5.21M | Sell |
22,484
-409
| -2% | -$83.3K | 0.78% | 32 |
|
|
2025
Q2 | $4.25M | Sell |
22,893
-8,788
| -28% | -$1.63M | 0.68% | 35 |
|
|
2025
Q1 | $6.64M | Sell |
31,681
-960
| -3% | -$187K | 0.94% | 25 |
|
|
2024
Q4 | $5.8M | Sell |
32,641
-1,782
| -5% | -$328K | 0.82% | 31 |
|
|
2024
Q3 | $6.8M | Sell |
34,423
-7,200
| -17% | -$1.34M | 0.91% | 25 |
|
|
2024
Q2 | $7.14M | Sell |
41,623
-1,112
| -3% | -$184K | 0.77% | 33 |
|
|
2024
Q1 | $7.78M | Sell |
42,735
-14,306
| -25% | -$2.47M | 0.81% | 32 |
|
|
2023
Q4 | $8.84M | Buy |
57,041
+246
| +0.4% | +$35.9K | 0.91% | 28 |
|
|
2023
Q3 | $8.47M | Buy |
56,795
+26,833
| +90% | +$3.94M | 0.98% | 24 |
|
|
2023
Q2 | $4.04M | Sell |
29,962
-29,516
| -50% | -$4.33M | 0.57% | 44 |
|
|
2023
Q1 | $9.48M | Sell |
59,478
-58,850
| -50% | -$9M | 1.08% | 19 |
|
|
2022
Q4 | $18.1M | Buy |
+118,328
| New | +$18.1M | 1.26% | 21 |
|
|
2022
Q1 | $889K | Buy |
6,050
+153
| +3% | +$22.2K | 0.06% | 184 |
|
|
2021
Q4 | $807K | Sell |
5,897
-239
| -4% | -$28.2K | 0.05% | 197 |
|
|
2021
Q3 | $746K | Buy |
6,136
+282
| +5% | +$32.2K | 0.05% | 202 |
|
|
2021
Q2 | $665K | Buy |
5,854
+442
| +8% | +$49.8K | 0.05% | 201 |
|
|
2021
Q1 | $616K | Sell |
5,412
-362
| -6% | -$38.7K | 0.05% | 199 |
|
|
2020
Q4 | $626K | Buy |
5,774
+29
| +0.5% | +$2.79K | 0.05% | 187 |
|
|
2020
Q3 | $560K | Buy |
5,745
+124
| +2% | +$11.7K | 0.05% | 187 |
|
|
2020
Q2 | $532K | Buy |
5,621
+70
| +1% | +$6.16K | 0.06% | 181 |
|
|
2020
Q1 | $499K | Buy |
5,551
+1,968
| +55% | +$168K | 0.06% | 154 |
|
|
2019
Q4 | $350K | Buy |
3,583
+254
| +8% | +$21.1K | 0.04% | 184 |
|
|
2019
Q3 | $288K | Sell |
3,329
-3,128
| -48% | -$214K | 0.04% | 195 |
|
|
2019
Q2 | $420K | Sell |
6,457
-5,884
| -48% | -$462K | 0.06% | 159 |
|
|
2019
Q1 | $972K | Sell |
12,341
-526
| -4% | -$43K | 0.15% | 107 |
|
|
2018
Q4 | $1.04M | Buy |
12,867
+7,125
| +124% | +$627K | 0.17% | 96 |
|
|
2018
Q3 | $506K | Buy |
5,742
+1,102
| +24% | +$105K | 0.09% | 141 |
|
|
2018
Q2 | $430K | Buy |
4,640
+430
| +10% | +$42K | 0.09% | 152 |
|
|
2018
Q1 | $399K | Buy |
4,210
+1,896
| +82% | +$208K | 0.09% | 161 |
|
|
2017
Q4 | $224K | Sell |
2,314
-3
| -0.1% | -$283 | 0.06% | 184 |
|
|
2017
Q3 | $206K | Buy |
+2,317
| New | +$176K | 0.06% | 181 |
|
|
2017
Q2 | – | Sell |
-362
| Closed | -$23.5K | – | 181 |
|
|
2017
Q1 | $23.5K | Buy |
+362
| New | +$22.8K | 0.08% | 171 |
|
|
2016
Q3 | $132K | Sell |
2,089
-1,879
| -47% | -$122K | 0.04% | 203 |
|
|
2016
Q2 | $138K | Buy |
+3,968
| New | +$242K | 0.02% | 503 |
|
|
2015
Q4 | $30.8K | Buy |
+2,608
| New | +$150K | 0.01% | 756 |
|
Other funds holding ABBV
WealthPLAN Partners's ABBV Position: Q2 2026 in Review
WealthPLAN Partners reduced its AbbVie (ABBV) stake by 45% in Q2 2026, selling an estimated $1.64M and leaving 9,387 shares worth $2.36M. The position accounts for 0.45% of the portfolio, ranked #55.
WealthPLAN Partners first reported a position in ABBV in Q4 2015 and has held it in 38 quarters since. The position peaked at $18.1M in Q4 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- WealthPLAN Partners held 9,387 shares of AbbVie worth $2.36M as of Q2 2026.
- WealthPLAN Partners sold 7,628 AbbVie shares in Q2 2026, an estimated $1.64M.
- AbbVie made up 0.45% of WealthPLAN Partners's portfolio in Q2 2026, its #55 holding.
- WealthPLAN Partners first reported a position in AbbVie in Q4 2015 and has held it in 38 quarters since.
- WealthPLAN Partners's AbbVie position peaked at $18.1M in Q4 2022.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on WealthPLAN Partners's 13F filing for Q2 2026, filed 28 Jul 2026.